RemSleep Holdings, Inc. is a medical device manufacturer dedicated to forever changing the level of treatment provided to obstructive Sleep Apnea patients. Our focus is primarily designing and manufacturing devices and products for the treatment of Sleep Apnea and other respiratory conditions.
With over 30 years of collective experience in CPAP therapy, the REMSleep team has extensive knowledge and understanding of CPAP and the challenges of patient compliance. We diligently strive for our products to make the difference and improve the condition of those suffering from Sleep Apnea.
Founder and Chairman
Highly successful owner and operator of multiple businesses, offering sleep apnea interfaces, devices, and other respiratory equipment and supplies. In 1979 he founded Medical Gases Australia, growing it into a thriving national business by 1984. During this time he met Dr. Collin Sullivan, who became the Grandfather of CPAP therapy. In partnership with him, Medical Gases Australia placed the first patients in the world on CPAP therapy. He then started Medical Industries America in 1985 and began to design, build, manufacture, market and sell its own products. The company grew from zero sales to a $25M company in 15 years. Russell also owned and sold EVO Medical Solutions, a manufacturer and distributor of respiratory products and devices.
Founder, Designer, and CEO
Tom Wood has been awarded numerous U.S. Patents. Tom is the inventor and developer of Nasal Aire®, Nasal Aire II®, and Petite Nasal Aire®. He has 25 Years of experience as a respiratory therapist in ICU at Baylor Medical Center and Parkland Memorial hospitals. He dedicated two years to the Muscular Dystrophy Association and was responsible for the respiratory care of patients with Amyotrophic Lateral Sclerosis.
Jonathan B. Lane has 35 years of design and engineering experience. He was the CEO/Founder of Badencorp, and Director of Engineering/Co-founder of Searchmont Engine Company. He worked twelve years for various fortune 500 companies including Boeing, General Dynamics and Bell Helicopter. From there, he went on to form his own company, Badencorp, which specialized in providing engineering and design services across all disciplines within Aerospace, Automotive, Biomedical, Consumer Products and Heavy Industries.
The designer has been awarded 18 patents, 1 pending. The designers first product, Nasal-Aire, won the 2004 Frost and Sullivan Award for most innovative medical device of the year (see article below).
The NEW Deltawave is expected to be by far the greatest achievement.
PALO ALTO, Calif.
In a recent study entitled ‘Strategic Analysis of World Sleep Apnea Therapeutic Markets,’ Frost and Sullivan recognized InnoMed Technologies Inc.’s revolutionary facial interface, a product that can provide comfort to millions of people suffering from sleep apnea, with the 2004 Frost and Sullivan Award for Product Innovation. Since masks are a very important component of continuous positive airway pressure (CPAP) therapy for sleep apnea, a comfortable mask can be crucial for patient compliance. While a number of companies have focused their efforts on developing better masks, InnoMed Technologies has excelled with the development of Nasal-Aire, a truly innovative mask. It does not require any headgear and can be worn like an oxygen canula, providing highly effective therapy.
‘The lack of patient comfort and compliance is one of the biggest reasons for the failure of CPAP therapy, however, Nasal-Aire offers multiple benefits to patients including the freedom to speak, sleep in any direction and wear eyeglasses, which makes it a facial interface of choice,’ says Frost and Sullivan industry analyst Dhiraj Ajmani. For its innovative product that can help increase patient compliance in the CPAP market, InnoMed is the recipient of the 2004 Frost and Sullivan Award for Product Innovation. The award is presented each year to the company that has demonstrated excellence in new products and technologies within its industry.
The recipient company has shown innovation by launching a broad line of emerging products and technologies. InnoMed’s’ product pipeline includes other novel products such as Nasal PAP Freestyle, a compact and comfortable interface, and the Nasal-Aire Critical Care device. Frost and Sullivan expects these products to expand the already growing market for Nasal-Aire. The company came into existence three years ago and is ISO1345-1996-certified, and the Nasal-Aire II has received its CE Mark. InnoMed’s products have found good acceptance in over 40 countries. The research-driven privately owned company is continuously developing innovative products in the fields of the rapidly growing sleep apnea and critical care markets. The simple and highly innovative, patient friendly Nasal-Aire is expected to revolutionize CPAP therapy, driving revenues for InnoMed Technologies.
About Frost and Sullivan
Founded in 1961, Frost and Sullivan is recognized as a global leader in growth consulting. Frost and Sullivan Awards are presented to companies that demonstrate excellence in the industry through diligence, commitment and innovative business strategies required to advance in the global marketplace. Frost and Sullivan rigorously analyzes specific criteria to determine award recipients in a vast variety of market industries and landscapes. For further information, visit www.frost.com.
210.247.2496 | email@example.com